Target Price | $162.30 |
Price | $124.20 |
Potential | 30.68% |
Number of Estimates | 23 |
23 Analysts have issued a price target Illumina 2026 . The average Illumina target price is $162.30. This is 30.68% higher than the current stock price. The highest price target is $250.00 101.29% , the lowest is $120.00 3.38% . | |
A rating was issued by 28 analysts: 13 Analysts recommend Illumina to buy, 14 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Illumina stock has an average upside potential 2026 of 30.68% . Most analysts recommend the Illumina stock at Hold. |
1 Analyst has issued a sales forecast Illumina 2024 . The average Illumina sales estimate is $4.3b . This is 1.32% lower than the revenue of the last 12 months(TTM). The highest sales forecast is $4.3b 1.32% , the lowest is $4.3b 1.32% .
This results in the following potential growth metrics:
2023 | $4.5b | 1.75% |
---|---|---|
2024 | $4.3b | 3.82% |
2025 | $4.4b | 2.37% |
2026 | $4.7b | 5.47% |
2027 | $5.0b | 6.43% |
2028 | $5.2b | 5.37% |
12 Analysts have issued an Illumina EBITDA forecast 2024. The average Illumina EBITDA estimate is $1.2b . This is 13.13% lower than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $1.5b 10.38% , the lowest is $1.0b 26.47% .
This results in the following potential growth metrics and future EBITDA Margins:
2023 | $338m | 54.81% |
---|---|---|
2024 | $1.2b | 250.58% |
2025 | $1.2b | 5.46% |
2026 | $1.4b | 10.42% |
2027 | $1.6b | 12.54% |
2028 | $1.7b | 9.54% |
2023 | 7.50% | 54.01% |
---|---|---|
2024 | 27.35% | 264.45% |
2025 | 28.18% | 3.03% |
2026 | 29.50% | 4.68% |
2027 | 31.20% | 5.76% |
2028 | 32.43% | 3.94% |
6 Illumina Analysts have issued a net profit forecast 2024. The average Illumina net profit estimate is $-1.3b . This is 15.12% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $-798m 49.50% , the lowest is $-2.2b 38.30% .
This results in the following potential growth metrics and future Net Margins:
2023 | $-1.2b | 73.80% |
---|---|---|
2024 | $-1.3b | 15.48% |
2025 | $467m | 134.85% |
2026 | $672m | 43.74% |
2027 | $773m | 15.07% |
2028 | $811m | 4.85% |
2023 | -25.78% | 73.33% |
---|---|---|
2024 | -30.96% | 20.08% |
2025 | 10.54% | 134.04% |
2026 | 14.36% | 36.24% |
2027 | 15.53% | 8.15% |
2028 | 15.45% | 0.52% |
6 Analysts have issued a Illumina forecast for earnings per share. The average Illumina <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is $-8.49 . This is 15.10% higher than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is $-5.05 49.50% , the lowest is $-13.83 38.30% .
This results in the following potential growth metrics and future valuations:
2023 | $-7.35 | 73.80% |
---|---|---|
2024 | $-8.49 | 15.51% |
2025 | $2.96 | 134.86% |
2026 | $4.25 | 43.58% |
2027 | $4.89 | 15.06% |
2028 | $5.13 | 4.91% |
Current | -12.42 | 38.67% |
---|---|---|
2024 | -14.63 | 17.79% |
2025 | 41.99 | 387.01% |
2026 | 29.21 | 30.44% |
2027 | 25.39 | 13.08% |
2028 | 24.21 | 4.65% |
Based on analysts' sales estimates for 2024, the Illumina stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of 4.95 and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of 4.55 .
This results in the following potential growth metrics and future valuations:
Current | 4.88 | 10.13% |
---|---|---|
2024 | 4.95 | 1.39% |
2025 | 4.83 | 2.31% |
2026 | 4.58 | 5.18% |
2027 | 4.31 | 6.04% |
2028 | 4.09 | 5.10% |
Current | 4.49 | 12.52% |
---|---|---|
2024 | 4.55 | 1.34% |
2025 | 4.44 | 2.31% |
2026 | 4.21 | 5.18% |
2027 | 3.96 | 6.04% |
2028 | 3.76 | 5.10% |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.